INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTANEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. (“Charming” or the “Company”) (
NASDAQ: MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (
NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Charming Medical, Limited; Kit Wong; Ching Man Cheung; Josephine Yan Yeung; Leut Ming Gung; Shu Tai Victor Yu; Cathay Securities Inc.; WWC, P.C.; And Cogency Global, Inc. (collectively, the “Defendants”).
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Jan. 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (
NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charming Medical Limited - MCTANEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charming Medical Limited (“Charming Medical” or the “Company”) (
NASDAQ: MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (
NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MCTA Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Charming Medical, Limited Class ActionSAN DIEGO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Charming Medical, Limited (
NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025. The Company claims to “enhance[] the quality of life from the inside out by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology.”
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MCTA
The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (
NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (
NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Charming Medical Limited (MCTA) Shareholders to Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Charming Medical Limited (“Charming” or the “Company”) (
NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). Charming investors have until February 17, 2026 to file a lead plaintiff motion.
MCTA Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Class Action Against Charming Medical, Limited
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Charming Medical, Limited (
NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025. The Company claims to “enhance[] the quality of life from the inside out by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology.”
Law Offices of Howard G. Smith Encourages Charming Medical Limited (MCTA) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Charming Medical Limited (“Charming” or the “Company”) (
NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). Charming investors have until February 17, 2026 to file a lead plaintiff motion.
Law Offices of Frank R. Cruz Encourages Charming Medical Limited (MCTA) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Charming Medical Limited (“Charming” or the “Company”) (
NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the “Class Period”). Charming investors have until February 17, 2026 to file a lead plaintiff motion.
Securities Fraud Investigation Into Charming Medical Limited (MCTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Charming Medical Limited (“Charming” or the “Company”) (
NASDAQ: MCTA) investors concerning the Company’s possible violations of the federal securities laws.
Charming Medical Limited (MCTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Charming Medical Limited (“Charming” or the “Company”) (
NASDAQ: MCTA) investors concerning the Company’s possible violations of federal securities laws.
Securities Fraud Investigation Into Charming Medical Limited (MCTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Charming Medical Limited (“Charming” or the “Company”) (
NASDAQ: MCTA) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Charming Medical, Limited; Kit Wong; Ching Man Cheung; Josephine Yan Yeung; Leut Ming Gung; Shu Tai Victor Yu; Cathay Securities Inc.; WWC, P.C.; And Cogency Global, Inc. (collectively, the “Defendants”).
